{{Rsnum
|rsid=6013897
|Chromosome=20
|position=54125940
|Orientation=plus
|GMAF=0.2332
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;T)
| geno3=(T;T)
| CEU | 6.2 | 30.1 | 63.7
| HCB | 2.2 | 26.3 | 71.5
| JPT | 0.9 | 19.5 | 79.6
| YRI | 4.8 | 39.5 | 55.8
| ASW | 5.3 | 43.9 | 50.9
| CHB | 2.2 | 26.3 | 71.5
| CHD | 0.9 | 33.0 | 66.1
| GIH | 7.9 | 48.5 | 43.6
| LWK | 10.9 | 33.6 | 55.5
| MEX | 15.5 | 41.4 | 43.1
| MKK | 7.7 | 32.7 | 59.6
| TSI | 10.8 | 37.3 | 52.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=22629401
|Title=Evaluation of Genetic Markers as Instruments for Mendelian Randomization Studies on Vitamin D
|OA=1
}}
{{PMID Auto
|PMID=22649517
|Title=Polymorphisms related to the serum 25-hydroxyvitamin d level and risk of myocardial infarction, diabetes, cancer and mortality. The tromsø study
|OA=1
}}

{{PMID Auto
|PMID=20541252
|Title=Common genetic determinants of vitamin D insufficiency: a genome-wide association study.
|OA=1
}}

{{PMID Auto
|PMID=22701574
|Title=Instrumental variable estimation of the causal effect of plasma 25-hydroxy-vitamin D on colorectal cancer risk: a mendelian randomization analysis
|OA=1
}}

{{PMID Auto
|PMID=23377224
|Title=Genetic Variation in the Vitamin D Pathway in Relation to Risk of Prostate Cancer - Results from Breast and Prostate Cancer Cohort Consortium (BPC3)
|OA=1
}}

{{PMID Auto
|PMID=23924835
|Title=Genetic variant in vitamin D binding protein is associated with serum 25-hydroxyvitamin D and vitamin D insufficiency in southern Chinese
}}

{{PMID Auto
|PMID=22740028
|Title=An exploratory analysis of common genetic variants in the vitamin D pathway including genome-wide associated variants in relation to glioma risk and outcome.
|OA=1
}}

{{on chip | Affy GenomeWide 6}}